Safety Measures for use of PCAs with Basal Rates

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

5 posts / 0 new
Log in or register to post comments
Last post
Mon, 02/01/2021 - 13:50
#1
Daniel Kudryashov
Daniel Kudryashov's picture
Offline
Last seen: 3 months 3 days ago
Joined: 07/26/2018 - 19:27
Safety Measures for use of PCAs with Basal Rates

I would appreciate your response to the following:
1. Does your institution limit use of PCAs with basal rates on opioid-tolerant patients only?
2. Does your institutions limit the location where PCA​ with basal rate may be used (ICU, Step-Down, etc.?)
3. Any limits on prescribing authority of PCA with a basal rate (i.e. only a specific service(s) may initiate)?
4. Is EtCO2 monitoring required for patients on PCA, with or without basal rate?
5. Any other safety measures in place?
Thank you.

Tags: 

Top